Switch View
© BusinessWire
28.10.2025
ISIN: US28176E1082
Edwards Lifesciences Corp.
EW
LISTED
NYSE
Halper Sadeh LLC Encourages Edwards Lifesciences Corporation Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Edwards Lifesciences Corporation (NYSE: EW) breached their fiduciary duties to shareholders.
If you currently own Edwards stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back t...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In aTyr To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in aTyr between January 16, 2025 and September 12...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US1897631057
Co-Diagnostics Inc
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. Announces Pricing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
News Preview
SALT LAKE CITY, Oct. 28, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it has entered into a securities purchase agreement with several in...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© PR Newswire
28.10.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
SMLR FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Investors of the Semler Scientific Upcoming Lead Plaintiff Deadline on Tuesday, October 28, 2025
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Semler Scientific To Contact Him Directly To Discuss Their Options
If you suffered significant losses in Semler Scientific between...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
28.10.2025
ISIN: US1407553072
Tvardi Therapeutics Inc
TVRD
LISTED
NASDAQ
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner
James (Josh) Wilson
Encourages Investors Who Suffered Significant Losses In Tvardi To Contact Him Directly To Discuss Their Options...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US92214X1063
Varex Imaging Corp
VREX
LISTED
NASDAQ
Varex Schedules Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call
News Preview
Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the fourth quarter and fiscal year 2025, following the close of regular trading on Tuesday, November 18, 2025. The earnings news release will be followed by a conference call at 3:00 pm Mountain Time that day.
This call will be webcast li...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US53228F1012
LifeStance Health Group Inc
LFST
LISTED
NASDAQ
Calm Health Partners with LifeStance Health to Help Users Access High-Quality Mental Health Care
News Preview
Collaboration Will Simplify and Streamline Users' Ability to Find
Personalized Care Delivered by Licensed Mental Health Clinicians
PALO ALTO, Calif. and SCOTTSDALE, Ariz., Oct. 28, 2025 /PRNewswire/ -- Calm Health, Calm's evidence-based mental...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US51654W1018
Lantern Pharma Inc.
LTRN
LISTED
NASDAQ
Lantern Pharma Presents LP-284 Clinical Data at 25th LL&M Congress, Highlighting Complete Response in Therapeutically Exhausted DLBCL Patient & Therapeutic Potential in Advanced B-Cell Cancers.
News Preview
Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biopharmaceutical company leveraging its proprietary RADR® artificial intelligence platform to transform oncology drug discovery and development, today announced the presentation of clinical data from its ongoing Phase 1 trial of LP-284 at the 25th Annual Lymphoma, Leukemia & Myeloma (LL&...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US88023B1035
Tempus AI, Inc.
TEM
LISTED
NASDAQ
Tempus to Participate in the Stifel 2025 Healthcare Conference
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced that it will participate in the Stifel 2025 Healthcare Conference on Thursday, November 13 in New York City. Jim Rogers, Chief Financial Officer at Tempus, will participate in a fireside chat at 10:00 AM ET.
The live webcast will be availab...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US98978V1035
Zoetis Inc
ZTS
LISTED
NYSE
Zoetis Appoints Stephanie Tilenius to its Board of Directors
News Preview
Zoetis Inc. (NYSE: ZTS) today announced the appointment of Stephanie Tilenius to its Board of Directors, effective as of December 1, 2025. Ms. Tilenius brings extensive experience in technology-forward, digital health organizations to the Zoetis Board.
Ms. Tilenius is a serial entrepreneur and has founded several healthcare companies, including...
Themefolio
Profiler
Peergroup
© EQS Newswire
28.10.2025
ISIN: CH0038389992
BB Biotech AG
BION
LISTED
SIX
Edison issues report on BB Biotech (BION)
News Preview
London, UK, 28 October 2025
Edison issues report on BB Biotech (BION)
Edison issues report on BB Biotech (SIX: BION)
BB Biotech (BION) delivered strong Q325 results, underpinned by its focus on innovative biotech companies with differentiated clinical pipelines and promising long-term potential. NAV increased 24.0% (in CHF terms) and its s......
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
ISIN: US64051A1016
NeOnc Technologies Holdings Inc
NTHI
LISTED
NASDAQ
His Highness Sheikh Nahyan bin Zayed Al Nahyan Assumes Executive Chairmanship of NeOnc Technologies' Subsidiary, NuroMENA, Pioneering UAE-US Partnership in Brain Cancer Treatment
News Preview
CALABASAS, Calif. and ABU DHABI, United Arab Emirates, Oct. 28, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a multi-Phase 2 clinical-stage biopharmaceutical company pioneering therapies for central nervous system (CNS) cancers, announces a landmark development for global healthcare innovation, His...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Newsfile
28.10.2025
ISIN: CA46604F1099
Izotropic Corporation
IZO
LISTED
CSE
Izotropic Launches "Breast Imaging News" Page on BreastCT.com
News Preview
Vancouver, British Columbia, and Sacramento, California--(Newsfile Corp. - October 28, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US04963C2098
AtriCure Inc
ATRC
LISTED
NASDAQ
AtriCure Announces the First Patient Treated in the BoxX-NoAF Clinical Trial
News Preview
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced that the first patient was enrolled and treated in the Box Lesion Creation with Left Atrial Appendage Exclusion to Reduce the Occurrence o...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US30052C1071
Evolus Inc
EOLS
LISTED
NASDAQ
Evolus to Participate in 2025 Stifel Healthcare Conference
News Preview
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced members of its management team will participate in a fireside chat and investor meetings at the upcoming Stifel Healthcare Conference.
The fireside chat will take place on Tuesday, November 11, 2025, at 11...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US7140461093
Revvity Inc
RVTY
LISTED
NYSE
Revvity to Present at Upcoming Investor Conferences
News Preview
Revvity, Inc. (NYSE: RVTY), today announced it will present at the following investor conferences:
UBS Global Healthcare Conference 2025
Monday, November 10, 2025
8:00 a.m. ET - Max Krakowiak, senior vice president and chief financial officer
Jefferies 2025 London Healthcare Conference
Tuesday, November 18, 2025
2:00 p.m. GMT – Max Krakowiak...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US0043971052
Accuray Inc
ARAY
LISTED
NASDAQ
Accuray to Report First Quarter Fiscal 2026 Financial Results on November 5, 2025
News Preview
MADISON, Wis., Oct. 28, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2026, ended September 30, 2025, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on November 5, 2025....
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US02157Q1094
Alto Neuroscience, Inc.
ANRO
LISTED
NYSE
Alto Neuroscience to Participate in Upcoming Investor Conferences
News Preview
Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced that members of the Company’s management team will present at the following upcoming investor conferences:
Stifel 2025 Healthcare Conference, November 11...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US98956P1021
Zimmer Biomet Holdings Inc
ZBH
LISTED
NYSE
Zimmer Biomet Announces FDA Breakthrough Designation for World's First Iodine-Treated Total Hip Replacement System
News Preview
Prioritized Regulatory Review Process in the U.S. Follows Japan PMDA Approval in September
WARSAW, Ind., Oct. 28, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the U.S. Food and Drug Ad...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
ISIN: US03969K1088
Arcutis Biotherapeutics Inc
ARQT
LISTED
NASDAQ
Arcutis Outlines Strategy for Driving Sustainable Growth and Announces Third Quarter 2025 Financial Results
News Preview
Arcutis today outlined its strategy to achieve sustainable growth and reported financial results for the quarter ended September 30, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Lantheus Announces FDA Acceptance of New Drug Application for MK-6240, a PET Imaging Agent Targeting Tau in Alzheimer’s Disease
News Preview
PDUFA Date Set for August 13, 2026 PDUFA Date Set for August 13, 2026...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: AU000000CSL8
CSL Limited
CSL
LISTED
ASX
CSL wurde von der International Society for Pharmaceutical Engineering (ISPE) als Gesamtsieger der „2025 Facility of the Year Awards" ausgezeichnet
News Preview
Das Werk von CSL in Broadmeadows setzt neue Maßstäbe für verantwortungsbewusste Innovation und verbindet die Prinzipien von Pharma 4.0™ mit nachhaltigem Design, um die Plasma-Herstellung zu transformieren
BROADMEADOWS, AUSTRALIEN, 28. Oktober 2025 /PRNewswire/ -- Die Basis-Fraktionierungsanlage vo...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US64049M2098
Neogenomics Inc
NEO
LISTED
NASDAQ
NeoGenomics Reports Third Quarter 2025 Results
News Preview
NeoGenomics, Inc. (NASDAQ: NEO) (the “Company”), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced its third quarter results for the period ended September 30, 2025.
Third Quarter 2025 Highlights As Compared To Third Quarter 2024
Consolidated revenue increased 12% to a record...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
ISIN: US0396971071
Ardelyx Inc
ARDX
LISTED
NASDAQ
Ardelyx Presents Data that Continues to Support the Benefits of IBSRELA® (tenapanor) at the American College of Gastroenterology’s 2025 Annual Meeting
News Preview
IBSRELA patients reported treatment satisfaction in real-world survey...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US01438T1060
Aldeyra Therapeutics Inc
ALDX
LISTED
NASDAQ
Aldeyra Therapeutics Announces Positive Results from Phase 2 Clinical Trial in Alcohol-Associated Hepatitis, Focuses RASP Product Candidate Pipeline on Next-Generation Molecules
News Preview
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced achievement of statistically significant improvement in liver function in patients treated with ADX-629, an investigational new drug candidate, and focus...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: IE00B56GVS15
Alkermes Plc
ALKS
LISTED
NASDAQ
Alkermes plc Reports Third Quarter 2025 Financial Results
News Preview
— Third Quarter Revenues of $394.2 Million —
— GAAP Net Income of $82.8 Million and Diluted GAAP Earnings per Share of $0.49 —
— Company Raises 2025 Financial Expectations —
DUBLIN, Oct. 28, 2025 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today reported fi...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: IE00B56GVS15
Alkermes Plc
ALKS
LISTED
NASDAQ
Alkermes plc Reports Third Quarter 2025 Financial Results
News Preview
— Third Quarter Revenues of $394.2 Million —
— GAAP Net Income of $82.8 Million and Diluted GAAP Earnings per Share of $0.49 —
— Company Raises 2025 Financial Expectations —
DUBLIN, Oct. 28, 2025 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today reported fi...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: CA09076M2004
BioVaxys Technology Corp.
BIOV
LISTED
CSE
BIOVAXYS ANNOUNCES CONVERSION OF DEBENTURES
News Preview
// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES //
VANCOUVER, BC, Oct. 28, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") announces the conversion of outstanding unsecured conve...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: CA09076M2004
BioVaxys Technology Corp.
BIOV
LISTED
CSE
BIOVAXYS ANNOUNCES CONVERSION OF DEBENTURES
News Preview
// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES //
VANCOUVER, BC, Oct. 28, 2025 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") announces the conversion of outstanding unsecured convertible...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US23283X2062
Cytosorbents Corp
CTSO
LISTED
NASDAQ
In Memoriam: Dr. Robert Hawes Bartlett (1939-2025) - Father of Extracorporeal Membrane Oxygenation (ECMO) and Former CytoSorbents Chief Medical Officer
News Preview
PRINCETON, N.J., Oct. 28, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, honors the life and legacy of Dr. Robert Hawes Bartlett, MD (1939-2025), the company's former Ch...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US3724463027
Genprex, Inc.
GNPX
LISTED
NASDAQ
Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
News Preview
Reqorsa® Gene Therapy is a Potential Treatment for ALK-EML4 Positive Translocated Non-Small Cell Lung Cancer
Combining REQORSA with Alectinib Further Increased Apoptosis and Improved Treatment Outcomes in a Mouse Model...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
ISIN: US75629V1044
Recursion Pharmaceuticals Inc
RXRX
LISTED
NASDAQ
Recursion to Report Third Quarter 2025 Business Updates and Financial Results on November 5th
News Preview
Company to host public (L)earnings call on November 5th at 8:00 am ET / 6:00 am MT / 1:00 pm GMT Company to host public (L)earnings call on November 5th at 8:00 am ET / 6:00 am MT / 1:00 pm GMT...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
ISIN: US63909J1088
Nautilus Biotechnology Inc
NAUT
LISTED
NASDAQ
Nautilus Biotechnology Reports Third Quarter 2025 Financial Results
News Preview
SEATTLE, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the third quarter ended September 30, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
ISIN: US8776191061
Taysha Gene Therapies Inc
TSHA
LISTED
NASDAQ
Taysha Gene Therapies to Release Third Quarter 2025 Financial Results and Host Conference Call and Webcast on November 4
News Preview
DALLAS, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that it will report its financial results for...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
ISIN: US1717571079
Cidara Therapeutics, Inc.
CDTX
LISTED
NASDAQ
Cidara Therapeutics to Participate in November Investor Conferences
News Preview
SAN DIEGO, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced that company management will participate in the below November investor conferences....
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US46266C1053
IQVIA Holdings Inc
IQV
LISTED
NYSE
IQVIA Reports Third-Quarter 2025 Results
News Preview
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today reported financial results for the quarter ended September 30, 2025.
Third-Quarter 2025 Operating Results
Revenue for the third quarter of $4,10...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US42238H1086
HeartBeam, Inc.
BEAT
LISTED
NASDAQ
HeartBeam Teams Up With HeartNexus to Deliver Cardiologist-Level ECG Insights Anytime, Anywhere
News Preview
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced a partnership with HeartNexus, Inc., a network of board-certified cardiologists specializing in cardiac test interpretation, peer-to-peer consultations, and on-demand telemedicine visits....
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US6323071042
Natera Inc
NTRA
LISTED
NASDAQ
Natera Reports Strong Advanced Adenoma Data from Prospective PROCEED-CRC Trial, Demonstrating 22.5% Sensitivity and 91.5% Specificity
News Preview
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced another successful readout for its ECD program, which is evaluating a blood-based screening test for the detection of CRC and advanced adenomas (AA). This latest analysis from the U.S. based, prospective PROCEED-CRC clinical trial (NCT06620627) fo...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US45337C1027
Incyte Corp
INCY
LISTED
NASDAQ
Incyte Reports Third Quarter 2025 Financial Results and Provides Business Updates
News Preview
Incyte (Nasdaq:INCY) today reported financial results for the third quarter of 2025 and provided a business update.
“Our third-quarter results demonstrate strong growth across our product portfolio, with net product revenues increasing 19% year-over-year, which highlights the momentum in our business and effective commercial execution,” said Bil...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US0070021086
Adicet Bio Inc
ACET
LISTED
NASDAQ
Adicet Bio to Participate in a Fireside Chat at the Guggenheim 2nd Annual Healthcare Innovation Conference
News Preview
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that Chen Schor, President and Chief Executive Officer, will participate in a fireside chat at the Guggenheim 2nd Annual Healthcare Innovation Conference bein...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US5049221055
Labcorp Holdings Inc
LH
LISTED
NYSE
Labcorp Announces 2025 Third Quarter Results
News Preview
Updates Full-Year Guidance
Financial results from Operations for third quarter 2025 versus third quarter 2024:Revenue: $3.56 billion versus $3.28 billionDiluted EPS: $3.12 versus $2.00Adjusted EPS: $4.18 versus $3.50
Updated Full-Year Enterpris...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US88033G4073
Tenet Healthcare Corp
THC
LISTED
NYSE
Tenet Reports Strong Third Quarter 2025 Results; Raises 2025 Financial Outlook
News Preview
Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended September 30, 2025.
"Our high acuity service line focus and operational discipline enabled us to deliver strong same store revenue growth and attractive operational performance and free cash flow in the third quarter," said Saum Sutaria, M.D., Chai...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US58933Y1055
Merck & Co Inc
MRK
LISTED
NYSE
Merck Announces KEYTRUDA® (pembrolizumab) Plus WELIREG® (belzutifan) Met Primary Endpoint of Disease-Free Survival (DFS) in Certain Patients With Clear Cell Renal Cell Carcinoma (RCC) Following Nephrectomy
News Preview
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive topline results from the Phase 3 LITESPARK-022 trial in patients with clear cell renal cell carcinoma (RCC) following nephrectomy. In this study, KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, in combination with WELIREG® (belzutifan), Merck’s...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US05370A1088
Avidity Biosciences Inc
RNA
LISTED
NASDAQ
RNA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Avidity Biosciences, Inc. Is Fair to Shareholders
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Avidity Biosciences, Inc. (NASDAQ: RNA) to Novartis for $72.00 per share in cash is fair to Avidity shareholders.
Halper Sadeh encourages Avidity shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halp...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
ISIN: US09073M1045
Bio-Techne Corp
TECH
LISTED
NASDAQ
Bio-Techne Launches ProximityScope™ Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research
News Preview
Visualizes functional protein-protein interactions directly within fixed tissue at subcellular resolution
Enables simultaneous detection of protein proximity, RNA, and proteins on the same tissue section
Automates spatial multiomic workflows with the BOND RX platform from Leica...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
ISIN: US88322Q1085
TG Therapeutics Inc
TGTX
LISTED
NASDAQ
TG Therapeutics Completes Enrollment in the Phase 3 ENHANCE Trial Evaluating its New Simplified Dosing Schedule for BRIUMVI
News Preview
NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), announced today that enrollment has completed in the randomized cohort of the Phase 3 ENHANCE trial evaluating a consolidated Day 1 and Day 15 dosing schedule for IV BRIUMVI® (ublituximab-xiiy), the company’s novel, glycoengineered, anti-CD20 monoclonal antibody, in...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
ISIN: CA05476A1012
Ayurcann Holdings Corp
AYUR
LISTED
CSE
AYURCANN REPORTS FISCAL YEAR 2025 RECORD SALES OF $55,446,352 IN GROSS REVENUE, FEATURING 21% YEAR-OVER-YEAR INCREASE AND PROVIDES CORPORATE UPDATE
News Preview
Toronto, Ontario, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR; OTCQB: AYURF) (“Ayurcann” or the “Company”), a leading Canadian processing and manufacturing company specializing in cannabis 2.0 and 3.0 products, is pleased to announce its financial and operational results for the year ended June 30, 2025, the highlights of...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
ISIN: US7599161095
Repligen Corp
RGEN
LISTED
NASDAQ
Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance
News Preview
WALTHAM, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for its third quarter of 2025, covering the three- and nine- month periods ended September 30, 2025. Provided in this press release are financial performance...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US81663L2007
GeneDx Holdings Corp
WGS
LISTED
NASDAQ
GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights
News Preview
GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today reported its financial results for the third quarter of 2025.
“GeneDx’s accelerated growth reflects more than business momentum - it’s proof of the profound impact we’re making for families navigating rare disease and the broader...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US4448591028
Humana Inc
HUM
LISTED
NYSE
Humana Board Declares Payment of Quarterly Dividend to Stockholders
News Preview
Humana Inc. (NYSE: HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on January 30, 2026 to stockholders of record as of the close of business on December 26, 2025.
About Humana
Humana Inc. is committed to putting health first – for our teammates, our customers, and our co...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US58933Y1055
Merck & Co Inc
MRK
LISTED
NYSE
Merck and Eisai Announce WELIREG® (belzutifan) Plus LENVIMA® (lenvatinib) Met Primary Endpoint of Progression-Free Survival (PFS) in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma
News Preview
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Eisai today announced that the Phase 3 LITESPARK-011 trial evaluating the dual oral regimen of WELIREG® (belzutifan), Merck’s first-in-class oral hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor, plus LENVIMA® (lenvatinib), an orally available multiple receptor tyrosin...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
ISIN: US00534A1025
Invivyd Inc
IVVD
LISTED
NASDAQ
Invivyd to Host Webcast on the REVOLUTION Clinical Program for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
News Preview
NEW HAVEN, Conn., Oct. 28, 2025 (GLOBE NEWSWIRE) -- WHAT: Invivyd, Inc. (Nasdaq: IVVD) is hosting the previously announced live webcast to present an overview of the company’s REVOLUTION clinical program, Invivyd’s development program for VYD2311, a vaccine-alternative monoclonal antibody candidate for the prevention of COVID. The session will f...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US07725L1026
BeOne Medicines Ltd.
ONC
LISTED
NASDAQ
BeOne Medicines to Present at Upcoming Investor Conferences
News Preview
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in fireside chats at two upcoming investor conferences:
Guggenheim Second Annual Healthcare Innovation Conference on Monday, November 10, 2025 at 9:30 am EST; and
Jefferies Global Healthcare Conference in London on Mon...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
ISIN: US29384C1080
Entrada Therapeutics Inc
TRDA
LISTED
NASDAQ
Entrada Therapeutics to Present at Upcoming Investor Conferences
News Preview
Entrada Therapeutics announces that the Company will participate in two upcoming investor conferences....
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
ISIN: US5147661046
Lifecore Biomedical Inc
LFCR
LISTED
NASDAQ
Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market
News Preview
CHASKA, Minn. and TORRANCE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), and PolyPeptide Laboratories, Inc. (“PolyPeptide”), a global leader in peptide contract development and manufacturing, today announced the sig...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
ISIN: US67092M2089
Nutriband Inc.
NTRB
LISTED
NASDAQ
Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch
News Preview
Positive FDA meeting...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
ISIN: US5015751044
Kymera Therapeutics Inc
KYMR
LISTED
NASDAQ
Kymera Therapeutics to Report Third Quarter 2025 Financial Results on November 4, 2025
News Preview
WATERTOWN, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, will report third quarter 2025 financial results on November 4, 2025. The Company will host a video conference call and...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US7743743004
Rockwell Medical Inc
RMTI
LISTED
NASDAQ
Rockwell Medical to Exhibit at ASN Kidney Week 2025
News Preview
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that the Company is exhibiting its hemodialysis concentrates portfolio in Booth #316 at the American Society of Nephrology ("A...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2025
ISIN: US91324P1021
UnitedHealth Group Inc
UNH
LISTED
NYSE
UnitedHealth Group Reports Third Quarter 2025 Results and Raises Full Year 2025 Earnings Outlook
News Preview
UnitedHealth Group (NYSE: UNH) reported third quarter 2025 results, reflecting the continued execution on its performance agenda, refocus on its mission and culture, and return to sustained growth.
“We remain focused on strengthening performance and positioning for durable and accelerating growth in 2026 and beyond, and our results this quarter...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.10.2025
ISIN: US75886F1075
Regeneron Pharmaceuticals Inc
REGN
LISTED
NASDAQ
Regeneron Reports Third Quarter 2025 Financial and Operating Results
News Preview
TARRYTOWN, N.Y., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced financial results for the third quarter of 2025 and provided a business update....
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
